Clinical studies recruiting near Groningen

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

Study of Efficacy and Safety of Iptacopan in Participants With IC-MPGN
Phase 3 · Novartis Investigative Site · Novartis Pharmaceuticals · NCT05755386 a PRagmatic Observational Study of Congestion proFILes in patiEnts With Acute Heart Failure
Phase N/A · UMCG · University Medical Center Groningen · NCT06587854 Refining Adjuvant Treatment IN Endometrial Cancer Based On Molecular Features
Phase 2/Phase 3 · Universitair Medisch Centrum Groningen · Leiden University Medical Center · NCT05255653 Efficacy and Safety of MB-CART2019.1 vs. SoC in Lymphoma Patients
Phase 2 · University Medical Center Groningen · Miltenyi Biomedicine GmbH · NCT04844866 Telemedicine Follow-Up for Early Laryngeal Cancer: a Randomized Controlled Trial Comparing Care Close to Home Versus Sta
NA · University Medical Center Groningen · University Medical Center Groningen · NCT06940505 The DRAGON 2 Trial
NA · University Medical Center Groningen · Maastricht University · NCT05428735 PODOMOUNT-Basket, a Study to Test Whether BI 764198 Helps Adults and Adolescents With Different Types of Kidney Disease
Phase 2 · Universitair Medisch Centrum Groningen · Boehringer Ingelheim · NCT07355296 Spectral Cancer Tissue Recognition - I
Phase N/A · Martini Ziekenhuis · SPCTR · NCT07459062 A 52-week Study of Rilzabrutinib Efficacy and Safety Compared to Placebo in Adults Diagnosed With IgG4-related Disease
Phase 3 · UMCG-Site Number : 5280002 · Sanofi · NCT07190196 UCAN CAN-DU: Canada-Netherlands Personalized Medicine Network in Childhood Arthritis and Rheumatic Disease
Phase N/A · Beatrix Children's Hospital, UMCG · The Hospital for Sick Children · NCT06560606 Analysing Peripheral Skeletal Muscle Function Before and After Endobronchial Valve Treatment
Phase N/A · Univeristy Medical Center Groningen · University Medical Center Groningen · NCT06025500 PEP-buddy in COPD: Effect on Dyspnea Severity and Mechanism of Action
NA · UMCG · University Medical Center Groningen · NCT05938738 CPAP or BiPAP for Motion Mitigation During Radiotherapy
NA · University Medical Center Groningen · University Medical Center Groningen · NCT04986293 A Study of Rapcabtagene Autoleucel in Active, Refractory Systemic Lupus Erythematosus (SLE) or Lupus Nephritis (LN) Pati
Phase 2 · Novartis Investigative Site · Novartis Pharmaceuticals · NCT06581198 A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangement
Phase 1/Phase 2 · Local Institution - 4501 · Turning Point Therapeutics, Inc. · NCT03093116 No Guts No Glory Probiotics
Phase 2/Phase 3 · University Medical Center Groningen · University Medical Center Groningen · NCT07606014 Anastomotic Leakage Prevention by Endovascular Stenting of the Superior Mesenteric Artery
NA · Martini Ziekenhuis · Medisch Spectrum Twente · NCT07486570 Continuing Somatostatin Analogues Upon Progression in Neuroendocrine Tumour pAtients
Phase 4 · UMC Groningen · University Hospital, Antwerp · NCT05701241 EHRA-PATHS: Clinical and Health Economic Evaluation of New Care Pathways
NA · University Medical Center Groningen · University Medical Center Groningen · NCT05773768 Study of AZD5863 in Adult Participants With Advanced or Metastatic Solid Tumors
Phase 1/Phase 2 · Research Site · AstraZeneca · NCT06005493 [18F]F-FAPI PET-CT to Identify Carcinoma of Unknown Primary Origin
NA · UMC Groningen · Erasmus Medical Center · NCT06644716 EP102 Safety and Efficacy in METTL3 Modulation in Advanced Solid Tumors
Phase 1 · University Medical Center Groningen, University of Groningen · Epics Therapeutics · NCT07163325 A Multiple Ascending Dose Study Evaluating the Safety and Tolerability of a Novel Formulation of QRL-101 in Healthy Part
Phase 1 · ICON plc. · QurAlis Corporation · NCT07421778 A Study Comparing Tarlatamab, Durvalumab, Carboplatin, and Etoposide Versus Durvalumab, Carboplatin, and Etoposide in Fi
Phase 3 · Universitair Medisch Centrum Groningen · Amgen · NCT07005128 A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic So
Phase 1/Phase 2 · Universitair Medisch Centrum Groningen · Daiichi Sankyo · NCT06330064 A Study to Find Out if BI 764198 Helps Adults and Adolescents With a Kidney Condition Called Focal Segmental Glomerulosc
Phase 3 · Universitair Medisch Centrum Groningen · Boehringer Ingelheim · NCT07220083 Minimal Invasive Axillary Staging and Treatment After Neoadjuvant Systemic Therapy in Node Positive Breast Cancer
Phase N/A · Martini Hospital · Maastricht University Medical Center · NCT04486495 SPECT-CT vs MRI for the Diagnosis of Osteoarthritis in the Foot and Ankle
Phase N/A · Martini Hospital · Martini Hospital Groningen · NCT05912153 Iodine Uptake After a Low Iodine Diet
NA · UMCG · University Medical Center Groningen · NCT05599139 COntinue the SaMe Systemic Therapy After Local Ablative Therapy for Oligo Progression in Metastatic Breast Cancer - the
Phase 2 · Martini ziekenhuis · The Netherlands Cancer Institute · NCT05301881

Look up another city

Look up another condition